Display options
Cite
Vargas V, Allende H, Lecube A, et al. Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. World J Hepatol. 2012;4(12):382-8doi: 10.4254/wjh.v4.i12.382.
Vargas, V., Allende, H., Lecube, A., Salcedo, M. T., Baena-Fustegueras, J. A., Fort, J. M., Rivero, J., Ferrer, R., Catalán, R., Pardina, E., Ramón Y Cajal, S., Guardia, J., & Peinado-Onsurbe, J. (2012). Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. World journal of hepatology, 4(12), 382-8. https://doi.org/10.4254/wjh.v4.i12.382
Vargas, Víctor, et al. "Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients." World journal of hepatology vol. 4,12 (2012): 382-8. doi: https://doi.org/10.4254/wjh.v4.i12.382
Vargas V, Allende H, Lecube A, Salcedo MT, Baena-Fustegueras JA, Fort JM, Rivero J, Ferrer R, Catalán R, Pardina E, Ramón Y Cajal S, Guardia J, Peinado-Onsurbe J. Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. World J Hepatol. 2012 Dec 27;4(12):382-8. doi: 10.4254/wjh.v4.i12.382. PMID: 23355916; PMCID: PMC3554802.
Copy Download .nbib Format: NLM
Share it on

World J Hepatol. 2012 Dec 27;4(12):382-8. doi: 10.4254/wjh.v4.i12.382.

Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients.

World journal of hepatology

Víctor Vargas, Helena Allende, Albert Lecube, Maria Teresa Salcedo, Juan A Baena-Fustegueras, José M Fort, Joaquín Rivero, Roser Ferrer, Roberto Catalán, Eva Pardina, Santiago Ramón Y Cajal, Jaime Guardia, Julia Peinado-Onsurbe

Affiliations

  1. Víctor Vargas, Jaime Guardia, Liver Unit, Department of Medicine, Hospital Vall d'Hebron, Universitat Autònoma, 08028 Barcelona, Spain.

PMID: 23355916 PMCID: PMC3554802 DOI: 10.4254/wjh.v4.i12.382

Abstract

AIM: To evaluate the effects of surgical weight loss (Roux-en-Y gastric bypass with a modified Fobi-Capella technique) on non alcoholic fatty liver disease in obese patients.

METHODS: A group of 26 morbidly obese patients aged 45 ± 2 years and with a body mass index > 40 kg/m(2) who underwent open surgical weight loss operations had paired liver biopsies, the first at surgery and the second after 16 ± 3 mo of weight loss. Biopsies were evaluated and compared in a blinded fashion. The presence of metabolic syndrome, anthropometric and biochemical variables were also assessed at baseline and at the time of the second biopsy.

RESULTS: Percentage of excess weight loss was 72.1% ± 6.6%. There was a reduction in prevalence of metabolic syndrome from 57.7% (15 patients) to 7.7% (2 patients) (P < 0.001). Any significance difference was observed in aspartate aminotransferase or alanine aminotransferase between pre and postsurgery. There were improvements in steatosis (P < 0.001), lobular (P < 0.001) and portal (P < 0.05) inflammation and fibrosis (P < 0.001) at the second biopsy. There were 25 (96.1%) patients with non alcoholic steatohepatitis (NASH) in their index biopsy and only four (15.3%) of the repeat biopsies fulfilled the criteria for NASH. The persistence of fibrosis (F > 1) was present in five patients at second biopsy. Steatosis and fibrosis at surgery were predictors of significant fibrosis postsurgery.

CONCLUSION: Restrictive mildly malabsorptive surgery provides significant weight loss, resolution of metabolic syndrome and associated abnormal liver histological features in most obese patients.

Keywords: Bariatric surgery; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Obesity

References

  1. Hepatology. 2005 Jun;41(6):1313-21 - PubMed
  2. Diabetes Care. 2007 Jan;30 Suppl 1:S42-7 - PubMed
  3. Gastroenterology. 1990 Nov;99(5):1408-13 - PubMed
  4. Clin Liver Dis. 2004 Aug;8(3):535-47, viii - PubMed
  5. Am J Surg. 2002 Feb;183(2):117-23 - PubMed
  6. J Hepatol. 1997 Jul;27(1):103-7 - PubMed
  7. Am J Gastroenterol. 1999 Sep;94(9):2467-74 - PubMed
  8. Clin Liver Dis. 2007 Feb;11(1):173-89, x - PubMed
  9. Semin Liver Dis. 2004 Nov;24(4):371-9 - PubMed
  10. QJM. 1999 Feb;92(2):73-9 - PubMed
  11. Diabetologia. 1985 Jul;28(7):412-9 - PubMed
  12. Diabetes Metab. 2000 Apr;26(2):98-106 - PubMed
  13. Arch Surg. 1975 Aug;110(8):1039-42 - PubMed
  14. Dig Dis Sci. 2006 Jan;51(1):21-6 - PubMed
  15. Gut. 2004 Mar;53(3):413-9 - PubMed
  16. JAMA. 2002 Jan 16;287(3):356-9 - PubMed
  17. Hepatology. 1998 Jun;27(6):1463-6 - PubMed
  18. Surgery. 2004 Jan;135(1):48-58 - PubMed
  19. Hepatology. 2003 Oct;38(4):1008-17 - PubMed
  20. Obes Surg. 1995 Feb;5(1):55-60 - PubMed
  21. Arch Surg. 1987 May;122(5):610-4 - PubMed
  22. Semin Liver Dis. 2004 Nov;24(4):349-62 - PubMed
  23. Am J Gastroenterol. 2006 Feb;101(2):368-73 - PubMed
  24. J Hepatol. 1991 Mar;12(2):224-9 - PubMed
  25. Hepatology. 2004 Jun;39(6):1647-54 - PubMed
  26. Arch Surg. 1995 Mar;130(3):318-25 - PubMed
  27. Gastroenterology. 2006 May;130(6):1617-24 - PubMed
  28. Obes Surg. 1993 May;3(2):161-164 - PubMed
  29. Int J Obes Relat Metab Disord. 1998 Mar;22(3):222-6 - PubMed
  30. N Engl J Med. 1983 Apr 28;308(17):995-9 - PubMed
  31. Obes Surg. 2005 Sep;15(8):1154-60 - PubMed
  32. Am J Surg. 1996 Jan;171(1):74-9 - PubMed
  33. Hepatology. 2003 May;37(5):1202-19 - PubMed
  34. Gastroenterology. 2001 Jul;121(1):91-100 - PubMed
  35. Hepatology. 2003 Aug;38(2):413-9 - PubMed
  36. Ann Surg. 2005 Oct;242(4):610-7; discussion 618-20 - PubMed

Publication Types